The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 38%.
Bank Hapoalim B.M. BKHYY
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $124.67
Bank Hapoalim B.M. holds its Accumulation at $124.67.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 3 days |
| Price | $124.67 |
| Valuation | 10.60 trailing · N/A forward price to earnings |
| Values screen | FAIL |
| Beta | 0.34 |
The business, in plain words · what the numbers mean
| Trailing P/E | 10.6x reasonably valued |
| Revenue growth | 0.9% slow but positive growth |
| Profit margin | 40.8% highly profitable on every dollar of sales |
| Return on equity | 15.1% a solid return on shareholder capital |
| Beta | 0.34 barely tracks the market's swings |
| Market cap | $32.6B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BKHYY
- › 3 Middle Eastern Dividend Stocks Yielding Over 3% Simply Wall St. · 9 Jun 2026
- › Bank Hapoalim BM (BKHPF) Q1 2026 Earnings Call Highlights: Strong Profit Growth and Strategic ... GuruFocus.com · 20 May 2026
- › 3 Middle Eastern Dividend Stocks Yielding Up To 5.2% Simply Wall St. · 6 May 2026
- › A Look At Bank Hapoalim B.M (TASE:POLI) Valuation After A Strong 64.7% One Year Return Simply Wall St. · 6 Apr 2026
- › Ashtrom secures $200m in financing for Texas solar project Energy Monitor · 13 Mar 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BKHYY's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BKHYY trades on PNK. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 38%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $139.06 | -19.8% | · | $802 | -19.8% |
| 2 months | $131.02 | -14.9% | · | $852 | -14.9% |
| 3 months | $126.96 | -12.1% | $1.21 | $888 | -11.2% |
| 6 months | $117.39 | -5.0% | $1.21 | $961 | -3.9% |
| 1 year | $82.46 | +35.3% | $1.21 | $1,368 | +36.8% |
| 2 years | $43.50 | +156.4% | $3.56 | $2,646 | +164.6% |
| 3 years | $39.78 | +180.5% | $5.81 | $2,951 | +195.1% |
| 5 years | $32.46 | +243.7% | $10.02 | $3,745 | +274.5% |
Historical returns from market close data. Past performance does not guarantee future results.